In summary, our study demonstrates that abnormal accumulation of IRG1-mediated itaconate production contributes to HCC progression by the epigenetic link between macrophage metabolism and T-cell exhaustion and that ibuprofen can attenuate this process by targeting IRG1 and enhancing the efficacy of PD-1-dependent immunotherapy. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.